| # | Drug | Count |
|---|---|---|
| 0 | ISOTRETINOIN | 192 |
| 1 | VEDOLIZUMAB | 73 |
| 2 | ADALIMUMAB | 56 |
| 3 | INFLIXIMAB | 46 |
| 4 | AZATHIOPRINE | 44 |
| 5 | MESALAMINE | 33 |
| 6 | PREDNISONE | 32 |
| 7 | ADALIMUMAB-ADAZ | 17 |
| 8 | ADALIMUMAB-AATY | 16 |
| 9 | ADALIMUMAB-FKJP | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 3 | 0.0185 |
| 1 | ETRASIMOD | 10 | 0.0059 |
| 2 | SEVELAMER HYDROCHLORIDE | 3 | 0.0052 |
| 3 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 4 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 2 | 0.0050 |
| 5 | ISOTRETINOIN | 192 | 0.0038 |
| 6 | USTEKINUMAB-STBA | 1 | 0.0027 |
| 7 | CORTISOL | 1 | 0.0025 |
| 8 | DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 1 | 0.0019 |
| 9 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 192 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 89 |
| 2 | Integrin Receptor Antagonist [EPC] | 73 |
| 3 | Corticosteroid [EPC] | 67 |
| 4 | Aminosalicylate [EPC] | 56 |
| 5 | Purine Antimetabolite [EPC] | 44 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 7 | Proton Pump Inhibitor [EPC] | 18 |
| 8 | Interleukin-23 Antagonist [EPC] | 16 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 73 | 0.0008 |
| 1 | Retinoid [EPC] | 192 | 0.0008 |
| 2 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 3 | Aminosalicylate [EPC] | 56 | 0.0006 |
| 4 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 5 | Purine Antimetabolite [EPC] | 44 | 0.0004 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 7 | Interleukin-17A Antagonist [EPC] | 7 | 0.0002 |
| 8 | Interleukin-23 Antagonist [EPC] | 16 | 0.0002 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 3 | 0.0001 |